Presentation Information
[ST08-17(1O19e-01)]Pathophysiological significance of nitric oxide for long COVID and potential therapeutic strategies with the specific inhibitor of DNMT3B S-nitrosylation
○Yuto Moriya1, Sho Kubota1, Yuki Otsuka2, Atsushi Morimoto1, Yosuke Matsushita3, Kazuki Tokumasu2, Nobumasa Takasugi1, Toyomasa Katagiri3, Fumio Otsuka2, Takashi Uehara1 (1.Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2.Department of General Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 3.Laboratory of Biofunctional Medicine, National Institute of Biomemedical Innovation, Health and Nutrition)
Comment
To browse or post comments, you must log in.Log in